Merial: $70 mln for poultry vaccine plant
Merial, the Animal Health division of the sanofi-aventis Group, announced that Merial Animal Health Co. (China) held a ground-breaking ceremony for an expansion project at its plant located in the Nanchang Hi-tech Development Zone, China.
Merial Animal Health Co. (China), a venture of Merial Limited and the Group’s first production facility in China, has been in operation for almost 20 years.
The facility in Nanchang produces poultry vaccines for the domestic Chinese market. Upon completion of the expansion project, which earmarks an estimated total investment of over US$70 mln, the production capacity of the Nanchang plant will double.
The new facility covers a land of 50,000 sq. m,, with a phase I floor area of nearly 30,000 sq. m.
“Merial has been operating with our partners in China for nearly 20 years,” declared José Barella, Executive Chairman of Merial. “With the establishment of this new state-of-the art facility, we have the ability to further apply the latest in modern avian vaccine technology and further contribute to the country’s production of poultry protein, and help feed a vibrant and modern China.”
Join 31,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.
